糖尿病患者夏科神经骨关节病诊断后的急诊住院、截肢与生存:区域注册队列研究
该区域注册队列研究纳入127513名糖尿病患者中140例首次诊断夏科神经骨关节病(CNO)者,中位随访4.6年。结果显示87.9%急诊住院、31.4%截肢、37.9%死亡,5年生存率67%,5年无截肢生存率44%。晚期慢性肾病与不良结局风险升高相关,高足风险状态独立关联截肢和无截肢生存,高龄独立关联死亡率。
要点
- CNO诊断后不良结局常见且发生早,需优先监测和多学科管理。
- 高或活动性足风险状态独立关联截肢风险升高(SHR 8.52)。
- 晚期慢性肾病(4-5期)与所有不良结局风险升高相关。
核心结论
- CNO患者诊断后急诊住院、截肢和死亡发生率很高,且发生在诊断后早期。
- CNO可作为系统性脆弱性的标志,支持在常规临床中优先监测和多学科管理。
研究设计与样本
- 区域注册队列研究,使用苏格兰NHS Greater Glasgow and Clyde地区2015-2024年常规联动医疗数据。
- 从127513名成人糖尿病患者中识别出140例首次记录CNO诊断者,平均年龄59岁,67%为男性。
- 采用时间-事件方法和多变量回归估计事件概率并检验与临床特征的关联。
主要发现
- 中位随访4.6年期间,123例(87.9%)发生急诊住院,44例(31.4%)接受下肢截肢(小或大),53例(37.9%)死亡。
- 估计5年生存率为67%,5年无截肢生存率为44%(中位4.04年)。
- 晚期慢性肾病(4期和5期)与所有结局风险升高相关。
- 高或活动性足风险状态独立关联下肢截肢(亚分布风险比8.52;95% CI 2.05-35.45)和更短的无截肢生存(风险比2.09;95% CI 1.15-3.80)。
- 高龄独立关联更高的死亡率(风险比3.04;95% CI 1.50-6.16)。
临床怎么用
- 对CNO诊断后的糖尿病患者应优先监测急诊住院、截肢和死亡风险,尤其在诊断后早期。
- 评估足风险状态和慢性肾病分期有助于识别高危患者,应纳入多学科管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim for this study was to describe adverse outcomes after Charcot neuro-osteoarthropathy (CNO) diagnosis in adults with diabetes and examine variation by clinical and sociodemographic characteristics. RESEARCH DESIGN AND METHODS: A regional, registry-based cohort study was conducted using linked routinely collected health care data from adults with diabetes and a first recorded CNO diagnosis in the National Health Service Greater Glasgow and Clyde, Scotland (2015-2024). Outcomes were all-cause emergency hospitalization, lower-extremity amputation, all-cause mortality, and amputation-free survival. Time-to-event methods and multivariable regression were used to estimate event probabilities and tested associations with clinical characteristics. RESULTS: From 127,513 adults with diabetes, 140 individuals with a first recorded CNO diagnosis were identified; their mean age was 59 years, and 67% were men. During a median 4.6-year follow-up, 123 patients (87.9%) had an emergency admission, 44 (31.4%) underwent lower-extremity amputation (minor or major), and 53 (37.9%) died. The estimated 5-year survival was 67%, while 5-year amputation-free survival was 44% (median 4.04 years). Advanced chronic kidney disease (stages 4 and 5) was associated with higher risk across outcomes. High or active foot-risk status was independently associated with lower-extremity amputation (subdistribution hazard ratio 8.52; 95% CI 2.05-35.45) and shorter amputation-free survival (hazard ratio (HR) 2.09; 95% CI 1.15-3.80), and older age was independently associated with higher mortality rate (HR 3.04; 95% CI 1.50-6.16). CONCLUSIONS: Adverse outcomes in CNO were frequent and occurred early after diagnosis, with high rates of emergency hospitalization, amputation, and death. These findings support CNO as a marker of systemic vulnerability and highlight the need for prioritized surveillance and multidisciplinary management in routine clinical care.
引用
- Milbourn VEL, Barn R, Tieges Z, et al. Emergency Hospitalization, Amputation, and Survival After Charcot Neuro-Osteoarthropathy Diagnosis in People With Diabetes: A Regional Registry-Based Cohort Study. Diabetes Care. 2026. PMID: 42520058. doi:10.2337/dc26-0373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。